51 related articles for article (PubMed ID: 3114194)
1. Suppression by neurotropin of production of human immuno-deficiency virus by the virus-producing MOLT-4 cell line.
Imai H; Ikuta K; Ueda S; Suehiro S; Yamamoto N; Kato S
Jpn J Cancer Res; 1987 Jul; 78(7):648-50. PubMed ID: 3114194
[TBL] [Abstract][Full Text] [Related]
2. Amplification of human immuno-deficiency virus production from a virus-producing cell line in culture at high cell density.
Ikuta K; Imai H; Ueda S; Suehiro S; Yamamoto N; Kato S
Jpn J Cancer Res; 1987 Jul; 78(7):643-7. PubMed ID: 3114193
[TBL] [Abstract][Full Text] [Related]
3. Suppression of human immunodeficiency virus replication by 3'-azido-3'-deoxythymidine in various human hematopoietic cell lines in vitro: augmentation of the effect by lentinan.
Tochikura TS; Nakashima H; Kaneko Y; Kobayashi N; Yamamoto N
Jpn J Cancer Res; 1987 Jun; 78(6):583-9. PubMed ID: 3112074
[TBL] [Abstract][Full Text] [Related]
4. Substances affecting the infection and replication of human immunodeficiency virus (HIV).
Yamamoto N; Harada S; Nakashima H
AIDS Res; 1986 Dec; 2 Suppl 1():S183-9. PubMed ID: 3030346
[TBL] [Abstract][Full Text] [Related]
5. Sulfation of polysaccharides generates potent and selective inhibitors of human immunodeficiency virus infection and replication in vitro.
Nakashima H; Yoshida O; Tochikura TS; Yoshida T; Mimura T; Kido Y; Motoki Y; Kaneko Y; Uryu T; Yamamoto N
Jpn J Cancer Res; 1987 Nov; 78(11):1164-8. PubMed ID: 2447045
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro.
Nakashima H; Matsui T; Harada S; Kobayashi N; Matsuda A; Ueda T; Yamamoto N
Antimicrob Agents Chemother; 1986 Dec; 30(6):933-7. PubMed ID: 2434024
[TBL] [Abstract][Full Text] [Related]
7. Zidovudine treatment for AIDS.
Hopkins S
Nurs Times; 1987 Sep 30-Oct 6; 83(39):64-5. PubMed ID: 3479753
[No Abstract] [Full Text] [Related]
8. Reverse transcriptase (RT)-independent as well as RT-dependent HIV-1 replication exists in syncytia following cell fusion.
Takami Y; Ito M; Baba M; Ikuta K; Tanabe F; Shigeta S
Fukushima J Med Sci; 1999 Jun; 45(1):13-24. PubMed ID: 10748552
[TBL] [Abstract][Full Text] [Related]
9. Effect of 3'-azido-2',3'-dideoxythymidine (AZT) and neutralizing antibody on human immunodeficiency virus (HIV)-induced cytopathic effects: implication of giant cell formation for the spread of virus in vivo.
Nakashima H; Tochikura T; Kobayashi N; Matsuda A; Ueda T; Yamamoto N
Virology; 1987 Jul; 159(1):169-73. PubMed ID: 3111083
[TBL] [Abstract][Full Text] [Related]
10. [Electron microscopic analysis of the effect of Trichophyton rubrum on the reproduction of the human immunodeficiency virus].
Bykovskiĭ AF; Katsitadze AG
Vestn Dermatol Venerol; 1989; (5):13-6. PubMed ID: 2773573
[TBL] [Abstract][Full Text] [Related]
11. [Study of anti-HIV activity of azidothymidine and fluorothymidine 5'-phosphonates].
Mamaeva OA; Pliasunova OA; Pokrovskiĭ AG; Diatkina NB; Arzumanova AA
Mol Biol (Mosk); 1994; 28(1):137-42. PubMed ID: 8145741
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates.
Chackerian B; Haigwood NL; Overbaugh J
Virology; 1995 Nov; 213(2):386-94. PubMed ID: 7491763
[TBL] [Abstract][Full Text] [Related]
13. Selective killing of human immunodeficiency virus-infected and -producing cells by liposomes containing diphtheria toxin fragment A.
Ikuta K; Ueda S; Uchida T; Okada Y; Kato S
Jpn J Cancer Res; 1987 Nov; 78(11):1159-63. PubMed ID: 3121551
[TBL] [Abstract][Full Text] [Related]
14. Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudine.
de Gans J; Lange JM; Derix MM; de Wolf F; Eeftinck Schattenkerk JK; Danner SA; Ongerboer de Visser BW; Cload P; Goudsmit J
AIDS; 1988 Feb; 2(1):37-40. PubMed ID: 3128994
[TBL] [Abstract][Full Text] [Related]
15. The morphogenesis of a Chinese strain of HIV-1 forming inclusion bodies in Jurkat-tat III cells.
Li QG; Zhang YJ; Liang Y; Feng CQ; Li YZ; Sjöberg R; Jiang Y; Wang NF; Wadell G
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):103-13. PubMed ID: 7749785
[TBL] [Abstract][Full Text] [Related]
16. The ratio of defective HIV-1 particles to replication-competent infectious virions.
Bourinbaiar AS
Acta Virol; 1994 Feb; 38(1):59-61. PubMed ID: 7520666
[TBL] [Abstract][Full Text] [Related]
17. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative.
Müller B; Daecke J; Fackler OT; Dittmar MT; Zentgraf H; Kräusslich HG
J Virol; 2004 Oct; 78(19):10803-13. PubMed ID: 15367647
[TBL] [Abstract][Full Text] [Related]
18. Significant changes in HIV antigen level in the serum of patients treated with azidothymidine.
Chaisson RE; Allain JP; Leuther M; Volberding PA
N Engl J Med; 1986 Dec; 315(25):1610-1. PubMed ID: 3466034
[No Abstract] [Full Text] [Related]
19. Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus.
Aquaro S; Bagnarelli P; Guenci T; De Luca A; Clementi M; Balestra E; Caliò R; Perno CF
J Med Virol; 2002 Dec; 68(4):479-88. PubMed ID: 12376954
[TBL] [Abstract][Full Text] [Related]
20. The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses.
Markowitz M; Vesanen M; Tenner-Racz K; Cao Y; Binley JM; Talal A; Hurley A; Jin X; Chaudhry MR; Yaman M; Frankel S; Heath-Chiozzi M; Leonard JM; Moore JP; Racz P; Nixon DF; Ho DD
J Infect Dis; 1999 Mar; 179(3):527-37. PubMed ID: 9952358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
